| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 |
| filingDate |
2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512f45e62e4725461c274c08e8c67b44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cad4a75c6f784749b55c0ee428b88b2 |
| publicationDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9353073-B2 |
| titleOfInvention |
Vortioxetine manufacturing process |
| abstract |
A process for the manufacture of vortioxetine is provided in which a compound of formula I, formula I is reacted with optionally substituted piperazine and 2,4-dimethylthiophenol(ate) followed by de-cmplexation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562872-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820984-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019040027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258617-B2 |
| priorityDate |
2013-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |